These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2142838)
1. Activation of CD8+ T cells by allogeneic class II-deficient B-cell lines derived from patients with bare lymphocyte syndrome. Jin Z; Yang SY Tissue Antigens; 1990 Mar; 35(3):136-43. PubMed ID: 2142838 [TBL] [Abstract][Full Text] [Related]
2. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. Koide J; Engleman EG J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266 [TBL] [Abstract][Full Text] [Related]
3. Synergistic T-T cell interaction present in alloreactivity: determination of 'MLR helper' T cell subsets. Asano Y; Komuro T; Tada T Int Immunol; 1990; 2(12):1203-11. PubMed ID: 1982500 [TBL] [Abstract][Full Text] [Related]
4. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses. Olsen AC; Fossum B; Kirkin AF; Zeuthen J; Gaudernack G Scand J Immunol; 1995 Apr; 41(4):357-64. PubMed ID: 7899823 [TBL] [Abstract][Full Text] [Related]
5. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943 [TBL] [Abstract][Full Text] [Related]
6. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses. Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140 [TBL] [Abstract][Full Text] [Related]
8. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. Fishwild DM; Benike CJ; Engleman EG J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276 [TBL] [Abstract][Full Text] [Related]
9. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation. Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288 [TBL] [Abstract][Full Text] [Related]
10. Differences between primed allogeneic T-cell responses and the primary mixed leucocyte reaction. Primed T cells become independent of the blocking effects of monoclonal antibodies against IL-1 beta and the CD5, CD11a (LFA-1), and CD11c (p 150,95) molecules. Odum N; Hofmann B; Morling N; Platz P; Ryder LP; Tvede N; Geisler C; Svejgaard A Scand J Immunol; 1988 Apr; 27(4):405-11. PubMed ID: 2966435 [TBL] [Abstract][Full Text] [Related]
11. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. Mizuochi T; Ono S; Malek TR; Singer A J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862 [TBL] [Abstract][Full Text] [Related]
12. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP. Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208 [TBL] [Abstract][Full Text] [Related]
13. Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells. Elbe A; Schleischitz S; Strunk D; Stingl G J Immunol; 1994 Oct; 153(7):2878-89. PubMed ID: 7522244 [TBL] [Abstract][Full Text] [Related]
14. Neuraminidase-treated macrophages stimulate allogenic CD8+ T cells in the presence of exogenous interleukin 2. Hirayama Y; Inaba K; Inaba M; Kato T; Kitaura M; Hosokawa T; Ikehara S; Muramatsu S J Exp Med; 1988 Oct; 168(4):1443-56. PubMed ID: 3262711 [TBL] [Abstract][Full Text] [Related]
15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro. Muraoka S Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712 [TBL] [Abstract][Full Text] [Related]
17. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714 [TBL] [Abstract][Full Text] [Related]
18. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis. Enssle KH; Fleischer B Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones. Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]